RSSCommentary

Has Vitamin D Had Its “Time In The Sun” For Melanoma?

| December 1, 2016

 Christopher J. Huerter, MD; Adam Vaudreuil;  Devendra K. Agrawal, PhD; Austin Huy Nguyen, MS Division of Dermatology and Department of Clinical and  Translational Science, Creighton University School of Medicine, Omaha, Nebraska Disclosure: The authors report no relevant conflicts of interest.  Abstract Growing evidence suggests a pivotal role for vitamin D in cancers, particularly melanoma. The […]

Continue Reading

Molecular Insights into Fully Human and Humanized Monoclonal Antibodies What are the Differences and Should Dermatologists Care?

| July 1, 2016

Lotus Mallbris, MD, PhD; Julian Davies, PhD; Andrew Glasebrook, PhD; Ying Tang, PhD; Wolfgang Glaesner, PhD; Brian J. Nickoloff, MD, PhD Eli Lilly and Company, Indianapolis, Indiana Disclosure: The authors are employees and stockholders of Eli Lilly and Company. This commentary was supported by Eli Lilly and Company, Indianapolis, Indiana. Abstract In recent years, a […]

Continue Reading

Superficial Radiation Therapy for the Treatment of Nonmelanoma Skin Cancers

| December 1, 2015

Sean McGregor, DO, PharmD; John Minni, DO, FAOCD; David Herold, MD, MBA Sean McGregor, DO, PharmD, is from Broward Health Medical Center, Fort Lauderdale, Florida; John Minni, DO, FAOCD, is from Waters Edge Dermatology, Port Saint Lucie, Florida; David Herold, MD, MBA, is from Waters Edge Dermatology, Palm Beach Gardens, Florida. Disclosure: The authors report […]

Continue Reading

Psoriasis The Poster Child for Bench-to-bedside Translational Medicine

| July 1, 2015 | 0 Comments

Lotus Mallbris, MD, phd; Brian J. Nickoloff, MD, phd Eli Lilly and Company, Indianapolis, Indiana Disclosure: Drs. Mallbris and Nickoloff are employees and stockholders of Eli Lilly and Company. This commentary was supported by Eli Lilly and Company, Indianapolis, Indiana.     Abstract As the largest and most visible organ, the skin provides opportunities to […]

Continue Reading

Real-Life Effectiveness of Topical Vitamin D and Corticosteroid Combination Therapy in Psoriasis Moving Beyond Clinical Trials

| February 1, 2015 | 0 Comments

Joshua Zeichner, MD Mount Sinai Hospital, New York, New York Disclosure: Dr. Zeichner has served as an advisor for LEO Pharma Inc. Abstract To provide successful care for psoriasis patients, treatments must be efficacious and safe as well as improve the patients’ overall well-being. Efficacy and safety are generally established by randomized, controlled clinical trials. […]

Continue Reading

Persistent Sexual Dysfunction and Depression in Finasteride Users for Male Pattern Hair Loss: A Serious Concern or Red Herring?

| December 1, 2014 | 0 Comments

Meena K. Singh, MD; Marc Avram, MD Department of Dermatology, Weill Cornell Medical College/NY Presbyterian Hospital, New York, New York  Disclosure: The authors report no relevant conflicts of interest. Abstract The use of finasteride for the treatment of male pattern hair loss has recently been the focus of media and internet attention for potential irreversible […]

Continue Reading

Is Decreased Ultraviolet Exposure During Childhood the Cause of the Increased Prevalence of Atopic Dermatitis?

| November 1, 2014 | 0 Comments

Kelly H. Tyler MD, FACOG; Matthew J. Zirwas MD, FAAD Drs. Tyler and Zirwas are from the Ohio State University, Division of Dermatology, Columbus, Ohio. Abstract There is a recent accumulation of data suggesting that decreased exposure to ultraviolet light in childhood could be a major factor contributing to the increasing rates of atopic dermatitis […]

Continue Reading